Articles
Using Survey Research to Develop Payer Strategies for an Existing Biologic’s Unique Indication in a Highly Competitive Market
Posted on November 29, 202111/29/21
How Pre-Launch Financial Exposure Modeling and Planning Can Help a Biopharmaceutical Reach More Patients
Posted on November 29, 202111/29/21
Developing a Channel Strategy Through Benchmarking For a First-in-Class Product Portfolio
Posted on November 29, 202111/29/21
European Guidelines and Real-World Evidence of Maintenance Treatments for Adults with Acute Myeloid Leukemia in First Complete Remission.
- Journal/Conference:
- European Hematology Association Annual Meeting
- Author(s):
- Ahmed M, Thompson G, Martin C, Cameron H, Chen C
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
Matching Adjusted Indirect Comparison (MAIC) of Oral Azacitidine (Oral-AZA) Versus Injectable AZA in Patients (pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy.
- Journal/Conference:
- Blood 138 (Supplement 1): 3015
- Author(s):
- Chen, C.; Huls, GA.; Cameron, H.; Suero, B.; Vasconcelos A.; Gaugler, L.; Beach, C.L.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
Clinical Trial Recruitment for Breast Cancer with Genetic Modifier
Posted on June 22, 20216/22/21
A large, global pharmaceutical company enrolling a Phase 3 clinical trial in breast cancer with a genetic modifier engaged Seeker Health by EVERSANA to create an engaging social media campaign to accelerate genetic testing, participant identification…
Pharma’s Mindset Regarding Medical Information with Carolyn Quon, PharmD
Posted on June 16, 20216/16/21